On August 11, Core Scientific, Inc. rose 5.3% in regular trading, trading at $20.38/share, with turnover of $23.18 million. The rebound was driven by multiple investment bank upgrades and a broader sector recovery.

On the news front, B. Riley raised its price target on Core Scientific from $33 to $42 while maintaining a Buy rating, and Keefe Bruyette upgraded the stock to Outperform from Market Perform with a revised target of $28. The analyst consensus average target stands at $36.71, providing significant valuation support at current levels. Sector peers Riot Platforms surged 10.15% and IREN gained 3.28% on the same session, reflecting broad capital inflows into the digital infrastructure space.

The move represents a technical rebound following the prior session's 5.05% decline, which was triggered by Q2 earnings showing a net loss of $3.32 per share versus the FactSet consensus estimate of a $0.06 loss. Revenue of $164.2 million beat estimates but failed to offset dilution concerns tied to AMD warrant arrangements under their 2.5-gigawatt data center partnership.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)